Pancreatic Cancer Health Risk for Diabetics: Persons Taking Diabetes Drugs Should Be Aware of a Potential Increased Pancreatic Cancer Health Risk That May Be Caused by Incretin Class Diabetic Drugs by Texas Diabetic Pancreatic Cancer Lawyer Jason S. Coomer
Recent scientific studies have shown that several diabetes drugs may cause an increased risk of pancreatic cancer. Persons taking Januvia, Janument, Victoza, Byetta, Onglyza, Tradjenta, Bydureon, Oseni, and other diabetes drugs should be aware of the potential dangers. If you have been taking a diabetes drug and have been diagnosed with Pancreatic Cancer or you have lost a loved one that was taking a diabetes drug and was diagnosed with pancreatic cancer, please report the adverse action to the prescribing medical doctor and FDA as soon as possible.
For persons more information on pancreatic cancer health risks to diabetics, please go to the following web page: Pancreatic Cancer Health Risk Warning: Incretin Class Diabetic Drugs May Cause Increase Risk of Pancreatic Cancer.
The Diabetes Drug Market is Over $40 Billion Each Year and Growing Rapidly Encouraging Drug Companies To Push Dangerous Diabetes Drugs For Profits
More than 300 million people worldwide suffer from diabetes, including about 30 million Americans. In 2010, the global prevalence of diabetes was estimated to have reached 285 million and predicted to reach 438 million by 2030. The corresponding figures for North America were 37.4 million in 2010 and 53.2 million by 2030 and in Europe 55.2 million in 2010 and 66.2 million in 2030. The global market for products in the management of diabetes currently stands at $41 billion and is on pace to grow to over $114 billion by 2018.
Pancreatic Cancer Detection: Understanding and Identifying Symptoms of Pancreatic Cancer Can Be Important In Early Detection and Treatment of Pancreatic Cancer Resulting in Higher Pancreatic Cancer Survival Rates
Symptoms of pancreatic cancer can include: dark urine and clay-colored stools, fatigue and weakness, jaundice (a yellow color in the skin, mucus membranes, or eyes), loss of appetite and weight loss, nausea and vomiting, pain or discomfort in the upper part of the belly or abdomen, back pain, blood clots, diarrhea, and indigestion. Diabetics who start experiencing these symptoms and are on incretin diabetes drugs should immediately contact their health care provider.